Search
Castle Biosciences Inc
CSTLAdd to Watchlist
32.520USD
-1.680-4.91%
Close 11-06 16:00（ET）
993.49MMarket Cap
LossP/E TTM
Castle Biosciences Inc (CSTL) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Castle Biosciences Inc in the past month.
Strong Buy
5 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
46.700USD+25.67%
CSTL Analyst Recommendation Trends
In the current month, CSTL has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CSTL average Analyst price target in the last month is 46.700.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
5
5
5
5
5
5
5
5
5
4
4
4
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
9
9
9
8
8
8
8
CSTL Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Guardant Health Inc
GH
12
14
2
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Financial Forecasting
Based on analysts' estimates, CSTL EPS is projected to reach -0.375 in FY2026Q4, following reported EPS of -0.124 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.49
-0.41
-0.37
-0.38
-0.43
Actual
-0.49
-0.07
-0.12
--
--
Surprise
+0.84%
+83.34%
+66.23%
--
--
FAQs
What is Castle Biosciences Inc's expected revenue for the next quarter?
Castle Biosciences Inc's expected revenue is 94.39M.
What is Castle Biosciences Inc's price target?
Analysts forecast that Castle Biosciences Inc's price target is USD 46.70, with the highest forecast at USD 60.00 and the lowest forecast at USD 35.00.
How have Castle Biosciences IncCSTL's recent earnings per share performed?
The market expectation was USD -0.12, while Castle Biosciences IncCSTL's earnings per share (EPS) for the previous quarter was USD -0.07. EPS for the next quarter is expected at USD -0.38.
What is the analyst rating for Castle Biosciences Inc?
Based on the ratings of Castle Biosciences Inc's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.